DKK3 and undifferentiated carcinoma: Approximately 56.1% (46 of 82) of invasive carcinoma tissues showed complete loss of DKK3; DKK3 was absent in most mucinous, serous, endometrioid, and undifferentiated carcinomas, while its expression was not reduced in transitional cell carcinoma.